HIV-AIDS
Jeffrey S. Akman, M.D. ’81, RESD ’85, vice president for health affairs, Walter A. Bloedorn Professor of Administrative Medicine, and dean, spoke to Psychiatric News about the crucial role psychiatrists play in the prevention and care for patients with HIV/AIDS.
New research co-authored by Douglas Nixon, M.D., Ph.D., chair of the Department of Microbiology, Immunology & Tropical Medicine and Walter G. Ross Professor of Basic Science Research, found that some individuals exposed to HIV-1, but who remain uninfected, have a certain pattern of virus-…
Jeffrey S. Akman, M.D., vice president for health affairs at GW and dean of the GW School of Medicine and Health Sciences, was sworn in as a new member of the Presidential Advisory Council on HIV/AIDS on May 21, 2015.
Brad Jones, assistant professor of microbiology, immunology, and tropical medicine, received a $180,000 grant from amfAR's generationCURE for his research looking at whether a novel combination therapy can eradicate the latent reservoirs of HIV that present a major barrier to finding a cure.
Dean Jeffrey Akman, M.D., shared his views on the history of lesbian, gay, bisexual, and transgender health at GW.
An interdisciplinary, city-wide consortium of researchers, led by Alan E. Greenberg, MD, MPH, professor and chair in the Department of Epidemiology and Biostatistics at Milken Institute School of Public Health, has received a grant from the National Institutes of Health for an expected $7.5 million…
First-year GW medical students present recommendations to improve the HIV Care Continuum during White House event.
Researchers at The Milken Institute School of Public Health, together with the Rodham Institute, were awarded a grant estimated to be funded at $23.8 million from the Centers for Medicare & Medicaid Services to study a new model that aims to improve HIV prevention and care while lowering…
Douglas Nixon, M.D., Ph.D., chair of the Department of Microbiology, Immunology, and Tropical Medicine, was published in the Cutting Edge section of the Journal of Immunology for his discovery of an antibody that can neutralize the HIV-1 fossil virus. This may lead to viable immunotherapy option…
Douglas Nixon, M.D., Ph.D., chair of the Department of Microbiology, Immunology, and Tropical Medicine, was featured in Infection Control Today for his recently published research on an antibody that can neutralize the HIV-1 fossil virus, published in the Cutting-edge Section of the Journal of…